Hiring in Biotechnology

• Discovery science

  Molecular biologists · Biochemists · Computational biologists

• Translational

  Translational scientists · Biomarker leads

• CMC & process

  Process development scientists · Upstream/downstream engineers · Tech-transfer leads

• Clinical & regulatory

  Clinical scientists · Regulatory affairs leads

• Modality fluency

  Modality is non-transferable. Rubrics separate small molecule, biologics, cell/gene, mRNA and synbio in scoring.

• Bench to translational

  Bench scientists and translational scientists reward different signal — captured separately.

• CMC and process

  Process development, tech transfer and scale-up are distinct disciplines with dedicated rubrics.

• Platform maturity

  Pre-clinical discovery platforms and clinical-stage biotechs need very different risk tolerance and hands-on-bench expectations from candidates.

Every candidate is scored against the role's rubric, and every score points back to a specific line in the CV. For biotechnology, these are the signals that carry weight:

• Modality-specific rubric
• Bench vs translational separated
• CMC track captured

• PhD in relevant biology
• GMP training for CMC

1. A ranked set of candidates, each with a score and the evidence behind it.
2. Eligibility checks resolved before the candidate reaches you — right to work, credentials, location model.
3. Salary expectation against your band, stated plainly, before you invest interview time.
4. One decision per candidate: advance, hold or decline, reversible for a short window.

Candidates stay invisible to you until we've reviewed them for your specific role, and contact details are released as a separate step.